BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11370527)

  • 21. Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in Beijing, China: analysis of results from China's top 3 hospital, 2009-2019.
    Liu Y; Ang Q; Wu H; Xu J; Chen D; Zhao H; Liu H; Guo X; Gu Y; Qiu H
    Virol J; 2020 Jul; 17(1):104. PubMed ID: 32660490
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis.
    Sherman ME; Lorincz AT; Scott DR; Wacholder S; Castle PE; Glass AG; Mielzynska-Lohnas I; Rush BB; Schiffman M
    J Natl Cancer Inst; 2003 Jan; 95(1):46-52. PubMed ID: 12509400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incident cervical HPV infections in young women: transition probabilities for CIN and infection clearance.
    Insinga RP; Perez G; Wheeler CM; Koutsky LA; Garland SM; Leodolter S; Joura EA; Ferris DG; Steben M; Hernandez-Avila M; Brown DR; Elbasha E; Muñoz N; Paavonen J; Haupt RM;
    Cancer Epidemiol Biomarkers Prev; 2011 Feb; 20(2):287-96. PubMed ID: 21300618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Frequency of cervical smear abnormalities within 3 years of normal cytology.
    Sawaya GF; Kerlikowske K; Lee NC; Gildengorin G; Washington AE
    Obstet Gynecol; 2000 Aug; 96(2):219-23. PubMed ID: 10908766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination of viral load thresholds in cervical scrapings to rule out CIN 3 in HPV 16, 18, 31 and 33-positive women with normal cytology.
    Snijders PJ; Hogewoning CJ; Hesselink AT; Berkhof J; Voorhorst FJ; Bleeker MC; Meijer CJ
    Int J Cancer; 2006 Sep; 119(5):1102-7. PubMed ID: 16570279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Epidemiology of cervical papillomavirus infections. Recent knowledge].
    Mougin C; Dalstein V; Prétet JL; Gay C; Schaal JP; Riethmuller D
    Presse Med; 2001 Jun; 30(20):1017-23. PubMed ID: 11433694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High prevalence of human papillomavirus type 58 in Chinese women with cervical cancer and precancerous lesions.
    Chan PK; Li WH; Chan MY; Ma WL; Cheung JL; Cheng AF
    J Med Virol; 1999 Oct; 59(2):232-8. PubMed ID: 10459162
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of high-risk human papillomavirus types and cervical squamous intraepithelial lesions in women over 30 years of age in St. Petersburg, Russia.
    Shipitsyna E; Zolotoverkhaya E; Kuevda D; Nasonova V; Romanyuk T; Khachaturyan A; Orlova O; Abashova E; Kostyuchek I; Shipulina O; Anttila A; Savicheva A
    Cancer Epidemiol; 2011 Apr; 35(2):160-4. PubMed ID: 20884314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Wait-and-see policy versus loop excision after two consecutive Pap-2 cervical smears: over time less surgery and an equivalent outcome; no substantial contribution to be expected from the detection of high risk human papillomavirus].
    Bekkers RL; Hanselaar AG; Melchers WJ; van Schaik JH; Boonstra H; Massuger LF
    Ned Tijdschr Geneeskd; 2003 Feb; 147(7):302-6. PubMed ID: 12622008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distribution of human papillomavirus types in ThinPrep Papanicolaou tests classified according to the Bethesda 2001 terminology and correlations with patient age and biopsy outcomes.
    Evans MF; Adamson CS; Papillo JL; St John TL; Leiman G; Cooper K
    Cancer; 2006 Mar; 106(5):1054-64. PubMed ID: 16421920
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human Papillomavirus Genotype Distribution among Thai Women with High-Grade Cervical Intraepithelial Lesions and Invasive Cervical Cancer: a Literature Review.
    Kietpeerakool C; Kleebkaow P; Srisomboon J
    Asian Pac J Cancer Prev; 2015; 16(13):5153-8. PubMed ID: 26225645
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening histories of women with CIN 2/3 compared with women diagnosed with invasive cervical cancer: a retrospective analysis of the Norwegian Coordinated Cervical Cancer Screening Program.
    Nygård JF; Nygård M; Skare GB; Thoresen SØ
    Cancer Causes Control; 2005 May; 16(4):463-74. PubMed ID: 15953989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-risk HPV testing in women with borderline and mild dyskaryosis: long-term follow-up data and clinical relevance.
    Denise Zielinski G; Snijders PJ; Rozendaal L; Voorhorst FJ; Runsink AP; de Schipper FA; Meijer CJ
    J Pathol; 2001 Oct; 195(3):300-6. PubMed ID: 11673826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Association between high-risk human papillomavirus DNA load and different histological grades of cervical neoplasia].
    Zhao FH; Hu SY; Wang SM; Chen F; Zhang X; Zhang WH; Pan QJ; Qiao YL
    Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Jul; 43(7):565-70. PubMed ID: 19954065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The terminology of pre-invasive cervical lesions in the UK cervical screening programme.
    Herrington CS
    Cytopathology; 2015 Dec; 26(6):346-50. PubMed ID: 26767601
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is the human papillomavirus test in combination with the Papanicolaou test useful for management of patients with diagnoses of atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesions?
    Lee NW; Kim D; Park JT; Kim A
    Arch Pathol Lab Med; 2001 Nov; 125(11):1453-7. PubMed ID: 11698001
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Application of human papillomavirus in screening for cervical cancer and precancerous lesions.
    Wang JL; Yang YZ; Dong WW; Sun J; Tao HT; Li RX; Hu Y
    Asian Pac J Cancer Prev; 2013; 14(5):2979-82. PubMed ID: 23803065
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HPV testing in primary screening of older women.
    Cuzick J; Beverley E; Ho L; Terry G; Sapper H; Mielzynska I; Lorincz A; Chan WK; Krausz T; Soutter P
    Br J Cancer; 1999 Oct; 81(3):554-8. PubMed ID: 10507785
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HPV 16 in multiple neoplastic lesions in women with CIN III.
    Hennig EM; Di Lonardo A; Venuti A; Holm R; Marcante ML; Nesland JM
    J Exp Clin Cancer Res; 1999 Sep; 18(3):369-77. PubMed ID: 10606184
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Value of HPV-DNA test in women with cytological diagnosis of atypical glandular cells (AGC).
    Zeferino LC; Rabelo-Santos SH; Villa LL; Sarian LO; Costa MC; do Amaral Westin MC; de Ângelo-Andrade LA; Derchain S
    Eur J Obstet Gynecol Reprod Biol; 2011 Nov; 159(1):160-4. PubMed ID: 21680079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.